Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous version tag. This appears to be a software version update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T23:56:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    No textual additions or deletions are present for this page. There are no changes to report.
    Difference
    0.0%
    Check dated 2026-05-09T00:00:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page content remains unchanged with no new information added or existing information removed.
    Difference
    0.0%
    Check dated 2026-05-01T21:39:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Updated the site page’s revision/version indicator from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T16:49:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T13:39:41.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma keyword was added and a Genetic and Rare Diseases Information Center resource link was added under Resources. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T23:46:32.000Z thumbnail image

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.